We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers... read more Featured Products: More products

Download Mobile App





Nova Biomedical Exhibits IVD Testing Solutions for POC and Critical Care at MEDICA 2022

By LabMedica International staff writers
Posted on 13 Nov 2022
Print article
Image: EMS Stat is a portable system for use in the emergency department to determine GLU, KET, LAC, Hb and HCT (Photo courtesy of Nova)
Image: EMS Stat is a portable system for use in the emergency department to determine GLU, KET, LAC, Hb and HCT (Photo courtesy of Nova)

Nova Biomedical (Waltham, MA, USA) is exhibiting its IVD testing solutions for point-of-care (POC) and critical care in the hospital and clinical areas at MEDICA 2022. MEDICA provides the medical device industry with a central market for innovative products and systems that result in an important contribution to the efficiency and quality of patient care.

On display at Nova’s booth is Allegro, a fast and compact POC capillary blood analyzer that offers a clinically important menu of 12 measured and individually selectable tests, as well as six calculated tests. All tests are measured with ready-to-use disposable cassettes or test strips and can be easily performed by non-technical personnel. Allegro uses a very small capillary blood drop for all blood tests, eliminating the need for venipuncture or a trained phlebotomist. With cartridge test times of six to nine minutes and the ability to measure two cartridges simultaneously, Allegro delivers fast results. Results are available during the patient visit - not after - making the patient-physician conversation more effective, reducing calls, letters and follow-up visits, and improving patient adherence to care recommendations.

Nova is also demonstrating EMS Stat, a portable system for use in the emergency department to determine GLU, KET, LAC, Hb and HCT. Stat EMS measures glucose, ketone bodies, lactate, hematocrit and hemoglobin from a capillary blood drop. Results are available within seconds, depending on the test. Combining disposable biosensor technology with portable electronics, Stat EMS provides simple, fast and accurate testing in the field. Stat EMS provides an important test menu for immediate patient assessment and faster, more effective emergency treatment. Stat EMS also assists in rapid triage and determining appropriate transport location for patients with trauma, sepsis or other special needs.

In addition, Nova is presenting the StatStrip Hemoglobin and Hematocrit Measurement System (StatStrip Hb/Hct), the only POC system that provides anemia screening and monitoring with measured rather than calculated Hb and Hct values. This important breakthrough is possible thanks to new, patented electrochemical technologies developed by Nova. Together with tiny capillary samples (1.6 µl) and results in 40 seconds, the StatStrip Hb/Hct improves clinical decision making at the POC. At MEDICA 2022, Nova is also showcasing BioProfile FLEX2 that combines Nova's breakthrough MicroSensor Card technology with optical sensing and freezing point osmometry to create an automated and comprehensive cell culture analyzer that eliminates chemical sensor maintenance, increases analyzer speed and reduces sample volume.

Related Links:
Nova Biomedical 

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HbA1c Test
HbA1c Rapid Test
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.